Market Research Logo

U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review

U.S. Stem Cell Inc (USRM) - Financial and Strategic SWOT Analysis Review

- provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

U.S. Stem Cell Inc (U.S. Stem Cell), formerly Bioheart, Inc, is a biotechnology company that focuses on the discovery, development and commercialization of cell based therapeutics products. The company repairs and replaces damaged or aged tissue, cells and organs and restoring their normal function. The company’s lead product MyoCell, is designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from a patient’s body, to improve cardiac function in chronic heart failure patients. Its services includes the development of proprietary cell therapy products based on regenerative medicine and cell therapy training services, cell collection and cell storage services, sale of cell collection and treatment kits for humans and animals, and operation of a cell therapy clinic. U.S. Stem Cell is headquartered in Sunrise, Florida, the US.

U.S. Stem Cell Inc Key Recent Developments

Jul 10,2018: Stem Cells Shows Promise For Repairing Torn Meniscus
May 14,2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
May 09,2018: U.S. Stem Cell Reports First Quarter Results
Apr 24,2018: Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
Apr 16,2018: USRM Reports 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Section 1 - About the Company
U.S. Stem Cell Inc - Key Facts
U.S. Stem Cell Inc - Key Employees
U.S. Stem Cell Inc - Key Employee Biographies
U.S. Stem Cell Inc - Major Products and Services
U.S. Stem Cell Inc - History
U.S. Stem Cell Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
U.S. Stem Cell Inc - Business Description
U.S. Stem Cell Inc - Corporate Strategy
U.S. Stem Cell Inc - SWOT Analysis
SWOT Analysis - Overview
U.S. Stem Cell Inc - Strengths
U.S. Stem Cell Inc - Weaknesses
U.S. Stem Cell Inc - Opportunities
U.S. Stem Cell Inc - Threats
U.S. Stem Cell Inc - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s, Lifesciences Financial Deals and Alliances
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
U.S. Stem Cell Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
May 14, 2018: Autologous Stem Cell Therapy May Hold Key to Regeneration
May 09, 2018: U.S. Stem Cell Reports First Quarter Results
Apr 24, 2018: Market Demand for Stem Cell Treatments Driving Steady Increase in USRM Sales
Mar 21, 2018: USRM Demonstrates 99% Reduction in Severity of Psoriasis Utilizing Autologous Stem Cells
Feb 06, 2018: USRM Seeing Explosive Increase in Demand for Stem Cell Therapy
Dec 01, 2017: Adipocell Stem Cell Therapy Shows Safety In A Wide Variety of Applications
Nov 01, 2017: U.S. Stem Cell Announces Clinical Expansion in U.S. Market
Oct 11, 2017: U.S. Stem Cell New Study Underscores the Safety of Autologous Stem Cell Therapy in Degenerative Diseases and Injuries
Aug 28, 2017: U.S. Stem Cell Clinic Acknowledges Warning Letter By The FDA and Responds
Aug 28, 2017: FDA warns US Stem Cell Clinic of significant deviations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
U.S. Stem Cell Inc, Key Facts
U.S. Stem Cell Inc, Key Employees
U.S. Stem Cell Inc, Key Employee Biographies
U.S. Stem Cell Inc, Major Products and Services
U.S. Stem Cell Inc, History
U.S. Stem Cell Inc, Joint Venture
U.S. Stem Cell Inc, Key Competitors
U.S. Stem Cell Inc, Ratios based on current share price
U.S. Stem Cell Inc, Annual Ratios
U.S. Stem Cell Inc, Annual Ratios (Cont...1)
U.S. Stem Cell Inc, Interim Ratios
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
U.S. Stem Cell Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
U.S. Stem Cell Inc, Performance Chart (2013 - 2017)
U.S. Stem Cell Inc, Ratio Charts
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
U.S. Stem Cell Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report